Refine by
Mammography Screening Articles & Analysis: Older
12 news found
Ralph Smathers MD, Director of Mammography Specialists Group, Los Gatos, CA “The detection of breast cancer with screening breast ultrasound has taken a large step forward with the FDA approval of the QVCAD system to be used with the GE Invenia/ABUS. ...
Kheiron Medical Technologies today announced the appointment of Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board ...
The Cancer Registry of Norway is one of the oldest and most respected organisations of its kind in the world. It collects data and produces statistics of the cancer prevalence in Norway, has the administrative responsibility for the public screening programme in Norway and has an extensive research activity. In a recent study, the Registry used over 120,000 screening examinations from a ...
But the numbers are destined to grow, since the pandemic has caused significant delays in screening and, on average, a 37.6% reduction in mammography scans [Source: Gisma: Mammography screening after the pandemic] It is therefore essential to have valid alternatives to make up for the delay in the prevention and early diagnosis ...
The system is indicated for use by trained and qualified healthcare providers to evaluate palpable and non-palpable breast abnormalities in adult patients who are referred for diagnostic imaging breast work-up following clinical presentation or other imaging examinations such as screening ...
Without forgetting that, at times, some elements of inaccessibility are hidden in the least predictable places, even in mammography equipment. Mammography is indeed a non-invasive diagnostic test that is usually performed by making the patient stand next to the device for a few minutes. ...
The system is indicated for use by trained and qualified healthcare providers to evaluate palpable and non-palpable breast abnormalities in adult patients who are referred for diagnostic imaging breast work-up following clinical presentation or other imaging examinations such as screening ...
The system is indicated for use by trained and qualified healthcare providers to evaluate palpable and non-palpable breast abnormalities in adult patients who are referred for diagnostic imaging breast work-up following clinical presentation or other imaging examinations such as screening mammography. Seno Medical Instruments, Inc. is a San Antonio, Texas-based ...
Rezolut, LLC and CureMetrix, Inc. have launched a pilot program in the Greater New York City area with the aim of pairing advanced technology with operational excellence to improve breast cancer detection in women receiving routine screening mammograms. Rezolut, LLC is a national, emerging platform of diagnostic medical imaging services, serving patients across the United States ...
Aurora Medical Technology Hong Kong (Aurora-HK) and The Chinese University of Hong Kong (CUHK) are pleased to announce the completion of a landmark collaboration agreement leveraging the shared interests and diverse expertise of the two entities. Led by Winnie chiu-wing Chu MD, Professor of radiology at CUHK and Abraham Morse MD, Medical Director of Aurora, the joint project will investigate the ...
The system is indicated for use by trained and qualified healthcare providers to evaluate palpable and non-palpable breast abnormalities in adult patients who are referred for diagnostic imaging breast work-up following clinical presentation or other imaging examinations such as screening mammography. Seno’s Chief Executive Officer Tom Umbel commented, ...
Being demonstrated for the first time since being approved, QVCAD reduces interpretation time of screening ABUS exams while maintaining diagnostic accuracy. In addition, QView successfully completed an installation of QVCAD at Northern Arizona Healthcare, the first joint installation with the Invenia™ ABUS system from GE Healthcare, approved by the FDA for breast cancer ...